PP

Payalben Prakash Bhabhor

Active Director Director DIN 09586201
DIN 09586201 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Payalben Prakash Bhabhor

Data last updated:

Payalben Prakash Bhabhor is a Director at Pathocare Pathology Laboratories Private Limited (since 2022). The company operates in Healthcare.

DIN 09586201
Primary Designation Director
Industry Healthcare
First Appointment 12 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 May 20222022Under Process Of Striking Off

Board colleagues of Payalben Prakash Bhabhor

Directorship timeline

Open interactive timeline →
Pathocare Pathology Laboratories Private Limited
Premium access

Shareholding and investment profile for Payalben Prakash Bhabhor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payalben Prakash Bhabhor

Payalben Prakash Bhabhor currently holds 1 directorship: Pathocare Pathology Laboratories Private Limited (Director, since 12 May 2022).

Payalben Prakash Bhabhor was first appointed on 12 May 2022 as Director at Pathocare Pathology Laboratories Private Limited.

The current boards of Payalben Prakash Bhabhor's companies include Ashish Natwarbhai Madiya (Pathocare Pathology Laboratories Private Limited), Viralkumar Ashvinbhai Patel (Pathocare Pathology Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available